sorafenib has been researched along with zinc sulfate in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (zinc sulfate) | Trials (zinc sulfate) | Recent Studies (post-2010) (zinc sulfate) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,919 | 241 | 588 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SS; Hong, SK; Jeong, CW; Jeong, SJ; Kwak, C; Lee, SE; Yoon, CY | 1 |
| Che, X; Chen, F; Chen, X; Fan, B; Song, X; Wang, J; Wang, X; Yang, D; Zhang, Z | 1 |
2 other study(ies) available for sorafenib and zinc sulfate
| Article | Year |
|---|---|
The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells.
Topics: Antineoplastic Agents; Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Docetaxel; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Insulin-Like Growth Factor I; Male; Niacinamide; Phenylurea Compounds; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-met; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sorafenib; Sunitinib; Taxoids; Zinc Sulfate | 2013 |
Zinc sensitizes prostate cancer cells to sorafenib and regulates the expression of Livin.
Topics: Actins; Adaptor Proteins, Signal Transducing; Apoptosis; Cell Line, Tumor; Cell Survival; Cytoskeleton; Drug Synergism; Humans; Inhibitor of Apoptosis Proteins; Male; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Prostatic Neoplasms; Sorafenib; Zinc Sulfate | 2013 |